Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to 15.82%.

  • Orthofix Medical's EBITDA Margin rose 5300.0% to 15.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.74%, marking a year-over-year increase of 52200.0%. This contributed to the annual value of 16.14% for FY2024, which is 41300.0% up from last year.
  • As of Q3 2025, Orthofix Medical's EBITDA Margin stood at 15.82%, which was up 5300.0% from 14.24% recorded in Q2 2025.
  • Orthofix Medical's EBITDA Margin's 5-year high stood at 33.26% during Q4 2021, with a 5-year trough of 34.54% in Q1 2023.
  • Over the past 5 years, Orthofix Medical's median EBITDA Margin value was 4.49% (recorded in 2021), while the average stood at 0.87%.
  • In the last 5 years, Orthofix Medical's EBITDA Margin skyrocketed by 336900bps in 2021 and then tumbled by -412200bps in 2023.
  • Over the past 5 years, Orthofix Medical's EBITDA Margin (Quarter) stood at 33.26% in 2021, then fell by -13bps to 28.78% in 2022, then plummeted by -137bps to 10.78% in 2023, then plummeted by -40bps to 15.09% in 2024, then surged by 205bps to 15.82% in 2025.
  • Its EBITDA Margin stands at 15.82% for Q3 2025, versus 14.24% for Q2 2025 and 26.52% for Q1 2025.